Gfi1 Loss Protects against Two Models of Induced Diabetes

<b>Background:</b> Although several approaches have revealed much about individual factors that regulate pancreatic development, we have yet to fully understand their complicated interplay during pancreas morphogenesis. Gfi1 is transcription factor specifically expressed in pancreatic ac...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tiziana Napolitano, Fabio Avolio, Serena Silvano, Sara Forcisi, Anja Pfeifer, Andhira Vieira, Sergi Navarro-Sanz, Marika Elsa Friano, Chaïma Ayachi, Anna Garrido-Utrilla, Josipa Atlija, Biljana Hadzic, Jérôme Becam, Anette Sousa-De-Veiga, Magali Dodille Plaisant, Shruti Balaji, Didier F. Pisani, Magali Mondin, Philippe Schmitt-Kopplin, Ez-Zoubir Amri, Patrick Collombat
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/6dfa825751eb42d887fe5a34c8b254f2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6dfa825751eb42d887fe5a34c8b254f2
record_format dspace
spelling oai:doaj.org-article:6dfa825751eb42d887fe5a34c8b254f22021-11-25T17:07:18ZGfi1 Loss Protects against Two Models of Induced Diabetes10.3390/cells101128052073-4409https://doaj.org/article/6dfa825751eb42d887fe5a34c8b254f22021-10-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/2805https://doaj.org/toc/2073-4409<b>Background:</b> Although several approaches have revealed much about individual factors that regulate pancreatic development, we have yet to fully understand their complicated interplay during pancreas morphogenesis. Gfi1 is transcription factor specifically expressed in pancreatic acinar cells, whose role in pancreas cells fate identity and specification is still elusive. <b>Methods:</b> In order to gain further insight into the function of this factor in the pancreas, we generated animals deficient for <i>Gfi1</i> specifically in the pancreas. <i>Gfi1</i> conditional knockout animals were phenotypically characterized by immunohistochemistry, RT-qPCR, and RNA scope. To assess the role of Gfi1 in the pathogenesis of diabetes, we challenged <i>Gfi1</i>-deficient mice with two models of induced hyperglycemia: long-term high-fat/high-sugar feeding and streptozotocin injections. <b>Results:</b> Interestingly, mutant mice did not show any obvious deleterious phenotype. However, in depth analyses demonstrated a significant decrease in pancreatic <i>amylase</i> expression, leading to a diminution in intestinal carbohydrates processing and thus glucose absorption. In fact, <i>Gfi1</i>-deficient mice were found resistant to diet-induced hyperglycemia, appearing normoglycemic even after long-term high-fat/high-sugar diet. Another feature observed in mutant acinar cells was the misexpression of ghrelin, a hormone previously suggested to exhibit anti-apoptotic effects on β-cells in vitro. Impressively, <i>Gfi1</i> mutant mice were found to be resistant to the cytotoxic and diabetogenic effects of high-dose streptozotocin administrations, displaying a negligible loss of β-cells and an imperturbable normoglycemia. <b>Conclusions:</b> Together, these results demonstrate that Gfi1 could turn to be extremely valuable for the development of new therapies and could thus open new research avenues in the context of diabetes research.Tiziana NapolitanoFabio AvolioSerena SilvanoSara ForcisiAnja PfeiferAndhira VieiraSergi Navarro-SanzMarika Elsa FrianoChaïma AyachiAnna Garrido-UtrillaJosipa AtlijaBiljana HadzicJérôme BecamAnette Sousa-De-VeigaMagali Dodille PlaisantShruti BalajiDidier F. PisaniMagali MondinPhilippe Schmitt-KopplinEz-Zoubir AmriPatrick CollombatMDPI AGarticlepancreas developmentamylaseghrelinmouse modelhigh-fat dietBiology (General)QH301-705.5ENCells, Vol 10, Iss 2805, p 2805 (2021)
institution DOAJ
collection DOAJ
language EN
topic pancreas development
amylase
ghrelin
mouse model
high-fat diet
Biology (General)
QH301-705.5
spellingShingle pancreas development
amylase
ghrelin
mouse model
high-fat diet
Biology (General)
QH301-705.5
Tiziana Napolitano
Fabio Avolio
Serena Silvano
Sara Forcisi
Anja Pfeifer
Andhira Vieira
Sergi Navarro-Sanz
Marika Elsa Friano
Chaïma Ayachi
Anna Garrido-Utrilla
Josipa Atlija
Biljana Hadzic
Jérôme Becam
Anette Sousa-De-Veiga
Magali Dodille Plaisant
Shruti Balaji
Didier F. Pisani
Magali Mondin
Philippe Schmitt-Kopplin
Ez-Zoubir Amri
Patrick Collombat
Gfi1 Loss Protects against Two Models of Induced Diabetes
description <b>Background:</b> Although several approaches have revealed much about individual factors that regulate pancreatic development, we have yet to fully understand their complicated interplay during pancreas morphogenesis. Gfi1 is transcription factor specifically expressed in pancreatic acinar cells, whose role in pancreas cells fate identity and specification is still elusive. <b>Methods:</b> In order to gain further insight into the function of this factor in the pancreas, we generated animals deficient for <i>Gfi1</i> specifically in the pancreas. <i>Gfi1</i> conditional knockout animals were phenotypically characterized by immunohistochemistry, RT-qPCR, and RNA scope. To assess the role of Gfi1 in the pathogenesis of diabetes, we challenged <i>Gfi1</i>-deficient mice with two models of induced hyperglycemia: long-term high-fat/high-sugar feeding and streptozotocin injections. <b>Results:</b> Interestingly, mutant mice did not show any obvious deleterious phenotype. However, in depth analyses demonstrated a significant decrease in pancreatic <i>amylase</i> expression, leading to a diminution in intestinal carbohydrates processing and thus glucose absorption. In fact, <i>Gfi1</i>-deficient mice were found resistant to diet-induced hyperglycemia, appearing normoglycemic even after long-term high-fat/high-sugar diet. Another feature observed in mutant acinar cells was the misexpression of ghrelin, a hormone previously suggested to exhibit anti-apoptotic effects on β-cells in vitro. Impressively, <i>Gfi1</i> mutant mice were found to be resistant to the cytotoxic and diabetogenic effects of high-dose streptozotocin administrations, displaying a negligible loss of β-cells and an imperturbable normoglycemia. <b>Conclusions:</b> Together, these results demonstrate that Gfi1 could turn to be extremely valuable for the development of new therapies and could thus open new research avenues in the context of diabetes research.
format article
author Tiziana Napolitano
Fabio Avolio
Serena Silvano
Sara Forcisi
Anja Pfeifer
Andhira Vieira
Sergi Navarro-Sanz
Marika Elsa Friano
Chaïma Ayachi
Anna Garrido-Utrilla
Josipa Atlija
Biljana Hadzic
Jérôme Becam
Anette Sousa-De-Veiga
Magali Dodille Plaisant
Shruti Balaji
Didier F. Pisani
Magali Mondin
Philippe Schmitt-Kopplin
Ez-Zoubir Amri
Patrick Collombat
author_facet Tiziana Napolitano
Fabio Avolio
Serena Silvano
Sara Forcisi
Anja Pfeifer
Andhira Vieira
Sergi Navarro-Sanz
Marika Elsa Friano
Chaïma Ayachi
Anna Garrido-Utrilla
Josipa Atlija
Biljana Hadzic
Jérôme Becam
Anette Sousa-De-Veiga
Magali Dodille Plaisant
Shruti Balaji
Didier F. Pisani
Magali Mondin
Philippe Schmitt-Kopplin
Ez-Zoubir Amri
Patrick Collombat
author_sort Tiziana Napolitano
title Gfi1 Loss Protects against Two Models of Induced Diabetes
title_short Gfi1 Loss Protects against Two Models of Induced Diabetes
title_full Gfi1 Loss Protects against Two Models of Induced Diabetes
title_fullStr Gfi1 Loss Protects against Two Models of Induced Diabetes
title_full_unstemmed Gfi1 Loss Protects against Two Models of Induced Diabetes
title_sort gfi1 loss protects against two models of induced diabetes
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/6dfa825751eb42d887fe5a34c8b254f2
work_keys_str_mv AT tiziananapolitano gfi1lossprotectsagainsttwomodelsofinduceddiabetes
AT fabioavolio gfi1lossprotectsagainsttwomodelsofinduceddiabetes
AT serenasilvano gfi1lossprotectsagainsttwomodelsofinduceddiabetes
AT saraforcisi gfi1lossprotectsagainsttwomodelsofinduceddiabetes
AT anjapfeifer gfi1lossprotectsagainsttwomodelsofinduceddiabetes
AT andhiravieira gfi1lossprotectsagainsttwomodelsofinduceddiabetes
AT serginavarrosanz gfi1lossprotectsagainsttwomodelsofinduceddiabetes
AT marikaelsafriano gfi1lossprotectsagainsttwomodelsofinduceddiabetes
AT chaimaayachi gfi1lossprotectsagainsttwomodelsofinduceddiabetes
AT annagarridoutrilla gfi1lossprotectsagainsttwomodelsofinduceddiabetes
AT josipaatlija gfi1lossprotectsagainsttwomodelsofinduceddiabetes
AT biljanahadzic gfi1lossprotectsagainsttwomodelsofinduceddiabetes
AT jeromebecam gfi1lossprotectsagainsttwomodelsofinduceddiabetes
AT anettesousadeveiga gfi1lossprotectsagainsttwomodelsofinduceddiabetes
AT magalidodilleplaisant gfi1lossprotectsagainsttwomodelsofinduceddiabetes
AT shrutibalaji gfi1lossprotectsagainsttwomodelsofinduceddiabetes
AT didierfpisani gfi1lossprotectsagainsttwomodelsofinduceddiabetes
AT magalimondin gfi1lossprotectsagainsttwomodelsofinduceddiabetes
AT philippeschmittkopplin gfi1lossprotectsagainsttwomodelsofinduceddiabetes
AT ezzoubiramri gfi1lossprotectsagainsttwomodelsofinduceddiabetes
AT patrickcollombat gfi1lossprotectsagainsttwomodelsofinduceddiabetes
_version_ 1718412718103330816